Horizon Investments’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.27M Buy
60,084
+16,643
+38% +$810K 0.04% 382
2026
Q1
$1.86M Sell
43,441
-89,303
-67% -$3.84M 0.02% 498
2025
Q4
$5.82M Buy
132,744
+76,363
+135% +$3.16M 0.07% 225
2025
Q3
$2.33M Sell
56,381
-43,661
-44% -$1.75M 0.03% 429
2025
Q2
$4.41M Buy
100,042
+99,976
+151,479% +$4M 0.07% 213
2025
Q1
$2.44K Hold
66
– – ﹤0.01% 712
2024
Q4
$2.2K Buy
+66
New +$2.14K ﹤0.01% 721

Other funds holding EXEL

Horizon Investments's EXEL Position: Q2 2026 in Review

Horizon Investments increased its Exelixis (EXEL) stake by 38% in Q2 2026, buying an estimated $810K and bringing the position to 60,084 shares worth $3.27M. The position accounts for 0.04% of the portfolio, ranked #382.

Horizon Investments first reported a position in EXEL in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.82M in Q4 2025. 760 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Horizon Investments held 60,084 shares of Exelixis worth $3.27M as of Q2 2026.
  • Horizon Investments bought 16,643 Exelixis shares in Q2 2026, an estimated $810K.
  • Exelixis made up 0.04% of Horizon Investments's portfolio in Q2 2026, its #382 holding.
  • Horizon Investments first reported a position in Exelixis in Q4 2024 and has held it in 7 quarters since.
  • Horizon Investments's Exelixis position peaked at $5.82M in Q4 2025.
  • 760 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Horizon Investments's 13F filing for Q2 2026, filed 13 Aug 2026.